Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rhythm Pharmaceuticals (RYTM) Prepaid Assets (2016 - 2025)

Rhythm Pharmaceuticals (RYTM) has disclosed Prepaid Assets for 10 consecutive years, with $26.1 million as the latest value for Q4 2025.

  • Quarterly Prepaid Assets rose 59.52% to $26.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $26.1 million through Dec 2025, up 59.52% year-over-year, with the annual reading at $26.1 million for FY2025, 59.52% up from the prior year.
  • Prepaid Assets for Q4 2025 was $26.1 million at Rhythm Pharmaceuticals, up from $23.6 million in the prior quarter.
  • The five-year high for Prepaid Assets was $26.1 million in Q4 2025, with the low at $6.7 million in Q4 2023.
  • Average Prepaid Assets over 5 years is $12.7 million, with a median of $11.1 million recorded in 2022.
  • The sharpest move saw Prepaid Assets crashed 43.49% in 2023, then surged 185.24% in 2025.
  • Over 5 years, Prepaid Assets stood at $12.4 million in 2021, then fell by 4.75% to $11.8 million in 2022, then tumbled by 43.49% to $6.7 million in 2023, then surged by 145.53% to $16.4 million in 2024, then soared by 59.52% to $26.1 million in 2025.
  • According to Business Quant data, Prepaid Assets over the past three periods came in at $26.1 million, $23.6 million, and $24.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.